[
  {
    "type": "MC",
    "category": "Intro/Legislation",
    "question": "Which Canadian law governs narcotics and controlled substances?",
    "options": [
      "Food and Drugs Act",
      "Controlled Drugs and Substances Act",
      "Canada Health Act",
      "Hazardous Products Act"
    ],
    "correct": 1,
    "answer_expl": "CDSA regulates production, distribution, and possession.",
    "tags": [
      "legislation"
    ],
    "id": "Q001"
  },
  {
    "type": "MC",
    "category": "Intro/Legislation",
    "question": "Which 'Seven Right' ensures 'Epi 1:1000 IM' is not given IV?",
    "options": [
      "Right Documentation",
      "Right Time",
      "Right Route",
      "Right Dose"
    ],
    "correct": 2,
    "answer_expl": "Right route is critical for safety.",
    "tags": [
      "seven rights"
    ],
    "id": "Q002"
  },
  {
    "type": "T/F",
    "category": "Intro/Legislation",
    "question": "All narcotics must be accounted for (administered, wasted, expired, broken).",
    "options": [
      "True",
      "False"
    ],
    "correct": 0,
    "answer_expl": "Accountability is required for controlled substances.",
    "tags": [],
    "id": "Q003"
  },
  {
    "type": "MC",
    "category": "Intro/Legislation",
    "question": "Which is an advantage of the IV route?",
    "options": [
      "Least infection risk",
      "Most rapidly effective",
      "Time\u2011released absorption",
      "Unaffected by dose errors"
    ],
    "correct": 1,
    "answer_expl": "IV is the fastest, but also most dangerous.",
    "tags": [],
    "id": "Q004"
  },
  {
    "type": "MC",
    "category": "PharmKinetics/Dynamics",
    "question": "'First\u2011pass metabolism' primarily affects which route?",
    "options": [
      "IV",
      "IM",
      "Oral (PO)",
      "IN"
    ],
    "correct": 2,
    "answer_expl": "GI absorption -> portal system -> liver before systemic.",
    "tags": [],
    "id": "Q005"
  },
  {
    "type": "FIB",
    "category": "PharmKinetics/Dynamics",
    "question": "Define drug half\u2011life: time required for the total amount of a drug in the body to _______",
    "correct": "decrease by half",
    "answer_expl": "Half-life informs repeat dosing intervals.",
    "tags": [],
    "id": "Q006"
  },
  {
    "type": "MC",
    "category": "PharmKinetics/Dynamics",
    "question": "Which factor increases absorption rate most?",
    "options": [
      "Smaller surface area",
      "Poor perfusion",
      "Large surface area (e.g., lungs)",
      "Protein binding"
    ],
    "correct": 2,
    "answer_expl": "Lung and sublingual membranes absorb rapidly.",
    "tags": [],
    "id": "Q007"
  },
  {
    "type": "MC",
    "category": "PharmKinetics/Dynamics",
    "question": "Which pair correctly matches receptor pharmacology?",
    "options": [
      "Agonist = blocks response",
      "Antagonist = triggers response",
      "Agonist\u2011antagonist = mixed activity",
      "Efficacy = binding strength"
    ],
    "correct": 2,
    "answer_expl": "Agonist\u2011antagonists can activate then block or partially activate.",
    "tags": [
      "receptor"
    ],
    "id": "Q008"
  },
  {
    "type": "MC",
    "category": "Autonomic (Alpha/Beta)",
    "question": "Alpha\u20111 stimulation causes:",
    "options": [
      "Bronchodilation",
      "Vasoconstriction",
      "\u2193 HR",
      "\u2193 Secretions"
    ],
    "correct": 1,
    "answer_expl": "Alpha\u20111 = vascular smooth muscle constriction.",
    "tags": [],
    "id": "Q009"
  },
  {
    "type": "MC",
    "category": "Autonomic (Alpha/Beta)",
    "question": "Beta\u20111 activation primarily:",
    "options": [
      "\u2191 HR/contractility/conduction",
      "Bronchodilation",
      "\u2193 NE release",
      "Miosis"
    ],
    "correct": 0,
    "answer_expl": "Beta\u20111 = heart.",
    "tags": [],
    "id": "Q010"
  },
  {
    "type": "MC",
    "category": "Autonomic (Alpha/Beta)",
    "question": "Beta\u20112 activation primarily:",
    "options": [
      "Bronchoconstriction",
      "Bronchodilation, uterine relaxation",
      "Bradycardia",
      "Miosis"
    ],
    "correct": 1,
    "answer_expl": "Beta\u20112 = lungs/smooth muscle.",
    "tags": [],
    "id": "Q011"
  },
  {
    "type": "MC",
    "category": "Autonomic (Alpha/Beta)",
    "question": "Ipratropium bromide works by:",
    "options": [
      "Beta\u20112 agonism",
      "Alpha\u20111 blockade",
      "Anticholinergic (muscarinic) blockade",
      "Alpha\u20112 agonism"
    ],
    "correct": 2,
    "answer_expl": "Anticholinergic prevents vagal bronchoconstriction & secretions.",
    "tags": [],
    "id": "Q012"
  },
  {
    "type": "MS",
    "category": "Autonomic (Alpha/Beta)",
    "question": "Pick all epinephrine receptor effects (1:1000 IM in anaphylaxis):",
    "options": [
      "Alpha\u20111 vasoconstriction",
      "Beta\u20111 \u2191 inotropy/chronotropy",
      "Beta\u20112 bronchodilation",
      "Muscarinic blockade"
    ],
    "correct": [
      0,
      1,
      2
    ],
    "answer_expl": "Epinephrine is mixed alpha/beta agonist.",
    "tags": [],
    "id": "Q013"
  },
  {
    "type": "SA",
    "category": "Autonomic (Alpha/Beta)",
    "question": "Contrast a beta\u20112 agonist vs an anticholinergic bronchodilator in asthma.",
    "rubric": "Mention beta\u20112 (smooth muscle relaxation) vs muscarinic blockade (\u2193 vagal tone, \u2193 mucus). Add rationale for combining in severe bronchospasm.",
    "sample_answer": "Beta\u20112 (salbutamol) relaxes airway smooth muscle; ipratropium blocks vagal bronchoconstriction and mucus. Combination is additive in moderate\u2011severe exacerbations.",
    "tags": [],
    "id": "Q014"
  },
  {
    "type": "MC",
    "category": "Med Assessment/Seven Rights",
    "question": "The '3 Cs and an E' before administration are:",
    "options": [
      "Color, Clarity, Concentration, Expiry",
      "Check, Confirm, Chart, Expired",
      "Count, Color, Concentration, Entry",
      "Color, Calculation, Consent, Expiry"
    ],
    "correct": 0,
    "answer_expl": "3 Cs + Expiry reduces med errors.",
    "tags": [],
    "id": "Q015"
  },
  {
    "type": "T/F",
    "category": "Med Assessment/Seven Rights",
    "question": "Always obtain vitals 5 minutes before and after every medication administration.",
    "options": [
      "True",
      "False"
    ],
    "correct": 0,
    "answer_expl": "Trend vital responses to meds.",
    "tags": [],
    "id": "Q016"
  },
  {
    "type": "WR",
    "category": "Med Assessment/Seven Rights",
    "question": "Write a safe\u2011medication workflow you will follow for nitroglycerin SL in suspected ACS.",
    "rubric": "Include: scene safety, history, focused exam, vitals & SBP, rule\u2011out PDE5 use & RVMI, 12\u2011lead note, 0.4 mg SL q5, monitor, reassess, withhold if SBP<100.",
    "sample_answer": "Sample should include 7 Rights, contraindications, and documentation.",
    "tags": [],
    "id": "Q017"
  },
  {
    "type": "MC",
    "category": "Medical Math",
    "question": "How many mg in 0.5 g?",
    "options": [
      "0.5 mg",
      "5 mg",
      "50 mg",
      "500 mg"
    ],
    "correct": 3,
    "answer_expl": "1 g = 1000 mg.",
    "tags": [],
    "id": "Q018"
  },
  {
    "type": "FIB",
    "category": "Medical Math",
    "question": "Volume (mL) = desired dose \u00d7 volume on hand \u00f7 ________",
    "correct": "concentration",
    "answer_expl": "Core dosing formula.",
    "tags": [],
    "id": "Q019"
  },
  {
    "type": "MC",
    "category": "Medical Math",
    "question": "You have 60 mg in 2 mL; you need 15 mg. Volume to give?",
    "options": [
      "0.25 mL",
      "0.5 mL",
      "1 mL",
      "1.5 mL"
    ],
    "correct": 1,
    "answer_expl": "(15 mg \u00d7 2 mL)/60 mg = 0.5 mL",
    "tags": [],
    "id": "Q020"
  },
  {
    "type": "MC",
    "category": "Medical Math",
    "question": "gtt/min for 500 mL NS over 30 min with 10 gtt set:",
    "options": [
      "83 gtt/min",
      "100 gtt/min",
      "167 gtt/min",
      "200 gtt/min"
    ],
    "correct": 2,
    "answer_expl": "(500\u00d710)/30=166.7\u2248167",
    "tags": [],
    "id": "Q021"
  },
  {
    "type": "MC",
    "category": "Medical Math",
    "question": "Parkland formula: Fluid = TBSA% \u00d7 kg \u00d7 ____ mL",
    "options": [
      "2",
      "3",
      "4",
      "6"
    ],
    "correct": 2,
    "answer_expl": "Give 1/2 in first 8h, remainder over next 16h.",
    "tags": [],
    "id": "Q022"
  },
  {
    "type": "SA",
    "category": "Medical Math",
    "question": "Convert 200 lb to kg using the exact formula and the 'divide by 2 then minus 10%' shortcut.",
    "rubric": "Show both methods and round properly.",
    "sample_answer": "200/2.2 \u2248 90.9 kg; 200/2=100; minus 10% (=10) \u2192 90 kg.",
    "tags": [],
    "id": "Q023"
  },
  {
    "type": "MC",
    "category": "IV Fluids & Blood",
    "question": "0.9% NaCl is:",
    "options": [
      "Hypotonic",
      "Isotonic",
      "Hypertonic",
      "Colloid"
    ],
    "correct": 1,
    "answer_expl": "NS is isotonic crystalloid.",
    "tags": [],
    "id": "Q024"
  },
  {
    "type": "MC",
    "category": "IV Fluids & Blood",
    "question": "RL contains which electrolytes?",
    "options": [
      "Na+, K+, Ca2+, Cl-, lactate",
      "Na+, Mg2+, PO4\u2212",
      "Na+ only",
      "Na+, glucose"
    ],
    "correct": 0,
    "answer_expl": "RL is balanced electrolyte solution with lactate buffer.",
    "tags": [],
    "id": "Q025"
  },
  {
    "type": "MC",
    "category": "IV Fluids & Blood",
    "question": "D5W is isotonic in the bag but becomes effectively:",
    "options": [
      "Isotonic",
      "Hypotonic",
      "Hypertonic",
      "Colloid"
    ],
    "correct": 1,
    "answer_expl": "Once dextrose is metabolized, free water acts hypotonic.",
    "tags": [],
    "id": "Q026"
  },
  {
    "type": "T/F",
    "category": "IV Fluids & Blood",
    "question": "Colloids are commonly used prehospital for hypovolemia.",
    "options": [
      "True",
      "False"
    ],
    "correct": 1,
    "answer_expl": "Colloids rarely used prehospital; risk of renal issues/shift.",
    "tags": [],
    "id": "Q027"
  },
  {
    "type": "MC",
    "category": "IV Fluids & Blood",
    "question": "Which fluid for dilution of IV drugs (compatibility) rather than volume replacement in shock?",
    "options": [
      "D5W",
      "NS",
      "RL",
      "2/3\u20131/3"
    ],
    "correct": 0,
    "answer_expl": "D5W often used for dilution; not for hypovolemic replacement.",
    "tags": [],
    "id": "Q028"
  },
  {
    "type": "MC",
    "category": "IV Fluids & Blood",
    "question": "Universal donor RBC type:",
    "options": [
      "AB+",
      "AB\u2212",
      "O\u2212",
      "O+"
    ],
    "correct": 2,
    "answer_expl": "O\u2212 RBCs lack A/B antigens & Rh factor.",
    "tags": [],
    "id": "Q029"
  },
  {
    "type": "MC",
    "category": "IV Fluids & Blood",
    "question": "Blood transfusion tubing must include:",
    "options": [
      "Heat exchanger",
      "Filter",
      "Microdrip chamber only",
      "Bacteria trap only"
    ],
    "correct": 1,
    "answer_expl": "Filter prevents clots/debris administration.",
    "tags": [],
    "id": "Q030"
  },
  {
    "type": "MC",
    "category": "IV Fluids & Blood",
    "question": "Acute hemolytic transfusion reaction hallmark:",
    "options": [
      "Urticaria only",
      "Fever + low back pain + hypotension",
      "Dry cough",
      "JVD + hypertension"
    ],
    "correct": 1,
    "answer_expl": "ABO incompatibility \u2192 hemolysis, back pain, shock.",
    "tags": [],
    "id": "Q031"
  },
  {
    "type": "SA",
    "category": "IV Fluids & Blood",
    "question": "Outline prehospital steps if you suspect transfusion reaction mid\u2011infusion.",
    "rubric": "Stop infusion, keep line with NS, monitor ABCs, vitals, treat shock, notify receiving facility, document.",
    "sample_answer": "Emphasize rapid recognition and supportive care.",
    "tags": [],
    "id": "Q032"
  },
  {
    "type": "MC",
    "category": "Cardiology Meds",
    "question": "ASA mechanism most relevant in ACS:",
    "options": [
      "Beta\u2011blockade",
      "Inhibits thromboxane A2 (platelet aggregation)",
      "Dissolves fibrin clots",
      "Increases coronary spasm"
    ],
    "correct": 1,
    "answer_expl": "Antiplatelet effect is key in ACS.",
    "tags": [],
    "id": "Q033"
  },
  {
    "type": "MC",
    "category": "Cardiology Meds",
    "question": "Adult ASA dose for suspected ACS:",
    "options": [
      "81 mg PO swallow",
      "160 mg PO chewed",
      "325 mg IV",
      "0.4 mg SL"
    ],
    "correct": 1,
    "answer_expl": "Chewed 160 mg (or 162 mg) unless contraindicated.",
    "tags": [],
    "id": "Q034"
  },
  {
    "type": "MC",
    "category": "Cardiology Meds",
    "question": "Nitroglycerin contraindication:",
    "options": [
      "Systolic BP > 100",
      "Recent PDE\u20115 inhibitor use",
      "Age > 65",
      "History of diabetes"
    ],
    "correct": 1,
    "answer_expl": "PDE\u20115 + nitrate can cause profound hypotension.",
    "tags": [],
    "id": "Q035"
  },
  {
    "type": "MC",
    "category": "Cardiology Meds",
    "question": "Preferred action before nitro:",
    "options": [
      "Give first then check BP",
      "Ensure IV access and SBP \u2265 100",
      "Administer 0.8 mg/hr patch first",
      "Give if RV MI present"
    ],
    "correct": 1,
    "answer_expl": "Monitor BP, withhold in RVMI and hypotension.",
    "tags": [],
    "id": "Q036"
  },
  {
    "type": "T/F",
    "category": "Cardiology Meds",
    "question": "PCP withholds nitro if monitor message indicates STEMI/ACUTE MI.",
    "options": [
      "True",
      "False"
    ],
    "correct": 0,
    "answer_expl": "Per AHS note, PCPs withhold nitro in STEMI message context (protocol note).",
    "tags": [],
    "id": "Q037"
  },
  {
    "type": "SA",
    "category": "Cardiology Meds",
    "question": "Explain why nitro can worsen RV infarct\u2011related hypotension.",
    "rubric": "RVMI is preload dependent; nitrates reduce preload causing drop in CO/BP.",
    "sample_answer": "Tie to right\u2011sided filling and hemodynamics.",
    "tags": [],
    "id": "Q038"
  },
  {
    "type": "MC",
    "category": "Endocrine Meds",
    "question": "Oral glucose route and dose:",
    "options": [
      "SL, 25 g x1",
      "PO, 25 g; q 5 min max 50 g (conscious)",
      "IV, 25 g",
      "IN, 2 mg"
    ],
    "correct": 1,
    "answer_expl": "Must be swallowed; give complex carb afterward.",
    "tags": [],
    "id": "Q039"
  },
  {
    "type": "MC",
    "category": "Endocrine Meds",
    "question": "D50W adult dose (AHS):",
    "options": [
      "10 g SIVP q5",
      "25 g SIVP/IO q5 to BGL>4.0 (max 50 g)",
      "5 g SIVP",
      "50 g SIVP single"
    ],
    "correct": 1,
    "answer_expl": "Titrate to effect/BGL; consider halved dose in stroke/CVA.",
    "tags": [],
    "id": "Q040"
  },
  {
    "type": "MC",
    "category": "Endocrine Meds",
    "question": "Glucagon adult IM dose when no IV:",
    "options": [
      "0.3 mg IM q5",
      "1 mg IM q15 (max 2 mg)",
      "2 mg IM single",
      "3 mg IN repeat"
    ],
    "correct": 1,
    "answer_expl": "Recheck BGL and provide complex carbohydrate afterward.",
    "tags": [],
    "id": "Q041"
  },
  {
    "type": "T/F",
    "category": "Endocrine Meds",
    "question": "Insulin is commonly administered by PCPs in the prehospital setting.",
    "options": [
      "True",
      "False"
    ],
    "correct": 1,
    "answer_expl": "Not given in PCP prehospital scope for hypoglycemia.",
    "tags": [],
    "id": "Q042"
  },
  {
    "type": "FIB",
    "category": "Endocrine Meds",
    "question": "Target BGL after treatment should be > ____ mmol/L",
    "correct": "4.0",
    "answer_expl": "Per AHS titration target.",
    "tags": [],
    "id": "Q043"
  },
  {
    "type": "MC",
    "category": "Resp/Antiemetic Meds",
    "question": "Salbutamol adult neb dose:",
    "options": [
      "2.5 mg",
      "5 mg",
      "10 mg",
      "20 mcg"
    ],
    "correct": 1,
    "answer_expl": "5 mg prn; often with ipratropium 500 mcg.",
    "tags": [],
    "id": "Q044"
  },
  {
    "type": "MC",
    "category": "Resp/Antiemetic Meds",
    "question": "Ipratropium adult neb dose:",
    "options": [
      "250 mcg",
      "500 mcg (max 1500 mcg)",
      "1 mg",
      "20 mcg"
    ],
    "correct": 1,
    "answer_expl": "Usually combined with 5 mg salbutamol.",
    "tags": [],
    "id": "Q045"
  },
  {
    "type": "MC",
    "category": "Resp/Antiemetic Meds",
    "question": "Dimenhydrinate (Gravol) adult dose/route:",
    "options": [
      "25 mg PO only",
      "50 mg SIVP/IM; 25 mg if >65 yrs",
      "1 mg/kg IV",
      "0.3 mg IM"
    ],
    "correct": 1,
    "answer_expl": "Antiemetic with antihistamine & anticholinergic properties.",
    "tags": [],
    "id": "Q046"
  },
  {
    "type": "MC",
    "category": "Resp/Antiemetic Meds",
    "question": "Diphenhydramine typical adult dose:",
    "options": [
      "1 mg/kg (max 50 mg) IM/IV",
      "0.15 mg/kg",
      "2 mg/kg",
      "10 mg"
    ],
    "correct": 0,
    "answer_expl": "Do not repeat; consider route and onset.",
    "tags": [],
    "id": "Q047"
  },
  {
    "type": "MS",
    "category": "Resp/Antiemetic Meds",
    "question": "Select common salbutamol side effects:",
    "options": [
      "Palpitations",
      "Tremor",
      "Bradycardia",
      "Nervousness"
    ],
    "correct": [
      0,
      1,
      3
    ],
    "answer_expl": "Beta\u20112 agonists often cause tremor, palpitations, nervousness.",
    "tags": [],
    "id": "Q048"
  },
  {
    "type": "SA",
    "category": "Resp/Antiemetic Meds",
    "question": "List signs of severe bronchospasm that warrant continuous nebs and prompt transport.",
    "rubric": "Use of accessory muscles, short sentences, silent chest, refractory hypoxemia.",
    "sample_answer": "Mention combination therapy and monitoring.",
    "tags": [],
    "id": "Q049"
  },
  {
    "type": "MC",
    "category": "Toxicology/Opioids",
    "question": "Opioid triad includes:",
    "options": [
      "Mydriasis, tachypnea, agitation",
      "Miosis, respiratory depression, ALOC",
      "Miosis, hyperventilation, rash",
      "Mydriasis, bradycardia, fever"
    ],
    "correct": 1,
    "answer_expl": "Pinpoint pupils with hypoventilation and ALOC.",
    "tags": [],
    "id": "Q050"
  },
  {
    "type": "MC",
    "category": "Toxicology/Opioids",
    "question": "Naloxone mechanism:",
    "options": [
      "Opioid agonist",
      "Opioid partial agonist",
      "Competitive opioid antagonist",
      "GABA antagonist"
    ],
    "correct": 2,
    "answer_expl": "Displaces opioids at receptors.",
    "tags": [],
    "id": "Q051"
  },
  {
    "type": "MC",
    "category": "Toxicology/Opioids",
    "question": "Adult IV naloxone titration per protocol:",
    "options": [
      "0.05 mg IV q2 min max 1 mg",
      "0.5 mg IV q2 min max 2 mg",
      "2 mg IV once only",
      "0.8 mg IM only"
    ],
    "correct": 0,
    "answer_expl": "Titrate to ventilation; avoid full withdrawal if possible.",
    "tags": [],
    "id": "Q052"
  },
  {
    "type": "MC",
    "category": "Toxicology/Opioids",
    "question": "Which is a known risk after naloxone?",
    "options": [
      "Non\u2011cardiogenic pulmonary edema",
      "Severe hypotension",
      "QT prolongation",
      "Hyperkalemia"
    ],
    "correct": 0,
    "answer_expl": "Rare but reported; monitor closely.",
    "tags": [],
    "id": "Q053"
  },
  {
    "type": "T/F",
    "category": "Toxicology/Opioids",
    "question": "Goal of naloxone is full awakening as fast as possible.",
    "options": [
      "True",
      "False"
    ],
    "correct": 1,
    "answer_expl": "Goal is adequate respirations; avoid precipitated withdrawal.",
    "tags": [],
    "id": "Q054"
  },
  {
    "type": "SA",
    "category": "Toxicology/Opioids",
    "question": "Explain 'duration of action may be shorter than opiate' and your transport plan.",
    "rubric": "Opioids may outlast naloxone \u2192 rebound hypoventilation; monitor and redose per protocol, transport all.",
    "sample_answer": "Include airway-first approach.",
    "tags": [],
    "id": "Q055"
  },
  {
    "type": "MC",
    "category": "Autonomic (Alpha/Beta)",
    "question": "Which finding most reflects Beta\u20112 therapy success?",
    "options": [
      "\u2193 HR",
      "\u2191 BP",
      "Improved wheeze and longer phrases",
      "Miosis"
    ],
    "correct": 2,
    "answer_expl": "Wheezing improves and speech lengthens.",
    "tags": [],
    "id": "Q056"
  },
  {
    "type": "MC",
    "category": "Autonomic (Alpha/Beta)",
    "question": "Alpha\u20111 blockade would most likely cause:",
    "options": [
      "Hypotension",
      "Bronchoconstriction",
      "Tachyarrhythmia",
      "Miosis"
    ],
    "correct": 0,
    "answer_expl": "Blocking vasoconstriction \u2192 vasodilation \u2192 lower BP.",
    "tags": [],
    "id": "Q057"
  },
  {
    "type": "MC",
    "category": "Autonomic (Alpha/Beta)",
    "question": "Which best describes 'sympathomimetic'?",
    "options": [
      "Blocks NE/Epi effects",
      "Mimics adrenergic effects",
      "Blocks muscarinic receptors",
      "Mimics PNS"
    ],
    "correct": 1,
    "answer_expl": "Sympathomimetics activate alpha/beta pathways.",
    "tags": [],
    "id": "Q058"
  },
  {
    "type": "FIB",
    "category": "Autonomic (Alpha/Beta)",
    "question": "Primary neurotransmitter of sympathetic post\u2011ganglionic neurons is ________",
    "correct": "norepinephrine",
    "answer_expl": "NE (except sweat glands).",
    "tags": [],
    "id": "Q059"
  },
  {
    "type": "FIB",
    "category": "Autonomic (Alpha/Beta)",
    "question": "Primary neurotransmitter of parasympathetic post\u2011ganglionic neurons is ________",
    "correct": "acetylcholine",
    "answer_expl": "ACh (muscarinic).",
    "tags": [],
    "id": "Q060"
  },
  {
    "type": "MAT",
    "category": "PharmKinetics/Dynamics",
    "question": "MATCH: (A) Affinity (B) Efficacy (C) Antagonist (D) Agonist \u2014 to definitions.",
    "match_key": "A=Binding attraction; B=Ability to produce effect; C=Blocks response; D=Triggers response",
    "tags": [],
    "id": "Q061"
  },
  {
    "type": "MC",
    "category": "Intro/Legislation",
    "question": "Which schedule requires physician order due to high abuse potential?",
    "options": [
      "OTC",
      "Prescription",
      "Controlled/Narcotic",
      "Natural Health Product"
    ],
    "correct": 2,
    "answer_expl": "Controlled/narcotics require orders & tracking.",
    "tags": [],
    "id": "Q062"
  },
  {
    "type": "MC",
    "category": "IV Fluids & Blood",
    "question": "Which is a sign of fluid overload?",
    "options": [
      "Dry mucous membranes",
      "Hypotension",
      "Peripheral edema and crackles",
      "Bradycardia"
    ],
    "correct": 2,
    "answer_expl": "Also JVD, bounding pulse; consider CHF/renal history.",
    "tags": [],
    "id": "Q063"
  },
  {
    "type": "FIB",
    "category": "Cardiology Meds",
    "question": "ASA dose for ACS (adult) = ____ mg PO chewed",
    "correct": "160",
    "answer_expl": "Chewed 160 mg (or 162 mg).",
    "tags": [],
    "id": "Q064"
  },
  {
    "type": "FIB",
    "category": "Cardiology Meds",
    "question": "Nitro SL spray single dose = ____ mg; q 5 min prn until SBP<100",
    "correct": "0.4",
    "answer_expl": "Hold if SBP < 100, PDE\u20115, or RVMI suspicion.",
    "tags": [],
    "id": "Q065"
  },
  {
    "type": "FIB",
    "category": "Resp/Antiemetic Meds",
    "question": "Epinephrine 1:1000 IM for anaphylaxis adult = ____ mg q 5 min to total 0.9 mg",
    "correct": "0.3",
    "answer_expl": "Vastus lateralis; monitor heart rhythm.",
    "tags": [],
    "id": "Q066"
  },
  {
    "type": "FIB",
    "category": "Resp/Antiemetic Meds",
    "question": "Salbutamol adult neb dose = ____ mg prn",
    "correct": "5",
    "answer_expl": "Often mixed with ipratropium 500 mcg.",
    "tags": [],
    "id": "Q067"
  },
  {
    "type": "FIB",
    "category": "Resp/Antiemetic Meds",
    "question": "Ipratropium adult neb dose = ____ mcg q ~5 min, max 1500 mcg",
    "correct": "500",
    "answer_expl": "Add-on bronchodilator via anticholinergic mechanism.",
    "tags": [],
    "id": "Q068"
  },
  {
    "type": "FIB",
    "category": "Resp/Antiemetic Meds",
    "question": "Dimenhydrinate adult dose = ____ mg SIVP/IM (25 mg if >65 yrs)",
    "correct": "50",
    "answer_expl": "For nausea/vertigo/motion sickness; sedating.",
    "tags": [],
    "id": "Q069"
  },
  {
    "type": "FIB",
    "category": "Resp/Antiemetic Meds",
    "question": "Diphenhydramine adult dose = ____ mg/kg (max 50 mg)",
    "correct": "1",
    "answer_expl": "After epinephrine in anaphylaxis.",
    "tags": [],
    "id": "Q070"
  },
  {
    "type": "FIB",
    "category": "Toxicology/Opioids",
    "question": "Naloxone IV titration step = ____ mg q 2 min (max 1 mg)",
    "correct": "0.05",
    "answer_expl": "Titrate to respirations, avoid full withdrawal.",
    "tags": [],
    "id": "Q071"
  },
  {
    "type": "FIB",
    "category": "Endocrine Meds",
    "question": "Oral glucose dose = ____ g PO q 5 min (max 50 g)",
    "correct": "25",
    "answer_expl": "Must be swallowed; give complex carb after.",
    "tags": [],
    "id": "Q072"
  },
  {
    "type": "FIB",
    "category": "Endocrine Meds",
    "question": "D50W adult = ____ g SIVP/IO q 5 min to BGL>4.0, max 50 g",
    "correct": "25",
    "answer_expl": "Consider half dose in suspected CVA/ICH.",
    "tags": [],
    "id": "Q073"
  },
  {
    "type": "FIB",
    "category": "Endocrine Meds",
    "question": "Glucagon adult IM = ____ mg q 15 min (max 2 mg)",
    "correct": "1",
    "answer_expl": "Use when no IV access.",
    "tags": [],
    "id": "Q074"
  },
  {
    "type": "FIB",
    "category": "Endocrine Meds",
    "question": "Insulin is used prehospital by PCPs: answer ____ (Yes/No)",
    "correct": "No",
    "answer_expl": "Not in PCP scope for hypoglycemia correction.",
    "tags": [],
    "id": "Q075"
  },
  {
    "type": "FIB",
    "category": "IV Fluids & Blood",
    "question": "Normal Saline is ____\u2011tonic crystalloid",
    "correct": "iso",
    "answer_expl": "Isotonic.",
    "tags": [],
    "id": "Q076"
  },
  {
    "type": "FIB",
    "category": "IV Fluids & Blood",
    "question": "Ringer\u2019s Lactate contains lactate buffer; avoid in severe ____ failure",
    "correct": "liver",
    "answer_expl": "Metabolism of lactate impaired in liver failure.",
    "tags": [],
    "id": "Q077"
  },
  {
    "type": "FIB",
    "category": "IV Fluids & Blood",
    "question": "D5W becomes effectively ____tonic after metabolism of dextrose",
    "correct": "hypo",
    "answer_expl": "Free water effect.",
    "tags": [],
    "id": "Q078"
  },
  {
    "type": "T/F",
    "category": "IV Fluids & Blood",
    "question": "3:1 rule \u2014 use 3 mL crystalloid per 1 mL blood lost.",
    "options": [
      "True",
      "False"
    ],
    "correct": 0,
    "answer_expl": "Two\u2011thirds leaves vascular space quickly.",
    "tags": [],
    "id": "Q079"
  },
  {
    "type": "MS",
    "category": "PharmKinetics/Dynamics",
    "question": "Pick factors that REDUCE absorption speed:",
    "options": [
      "Shock/hypoperfusion",
      "Large alveolar surface area",
      "Hypothermia",
      "Good muscular blood flow"
    ],
    "correct": [
      0,
      2
    ],
    "answer_expl": "Perfusion and temperature matter.",
    "tags": [],
    "id": "Q080"
  },
  {
    "type": "MC",
    "category": "Med Assessment/Seven Rights",
    "question": "Which is best to verify before D50W push?",
    "options": [
      "18g IV patency with NS running",
      "No NS needed",
      "Push fast without vein check",
      "Give IM"
    ],
    "correct": 0,
    "answer_expl": "Prevent extravasation/tissue injury.",
    "tags": [],
    "id": "Q081"
  },
  {
    "type": "WR",
    "category": "PharmKinetics/Dynamics",
    "question": "Explain protein binding vs free drug and clinical impact on onset/duration.",
    "rubric": "Discuss albumin binding delaying onset, prolonging duration; free drug is active; low albumin increases free fraction.",
    "sample_answer": "Tie to elderly/malnourished patients.",
    "tags": [],
    "id": "Q082"
  },
  {
    "type": "WR",
    "category": "Toxicology/Opioids",
    "question": "Outline a full Adult Opiate Overdose approach (primary -> drug).",
    "rubric": "Airway/ventilation first, BGL, titrated naloxone dosing, monitor for recurrence, transport all meds to hospital.",
    "sample_answer": "Emphasize ABCs over diagnostic Narcan.",
    "tags": [],
    "id": "Q083"
  },
  {
    "type": "WR",
    "category": "Resp/Antiemetic Meds",
    "question": "Write a combined bronchodilator plan for severe asthma/COPD exacerbation.",
    "rubric": "Continuous salbutamol nebs + scheduled ipratropium, steroids per ACP/ED, oxygen titration, reassess.",
    "sample_answer": "Note Beta\u20112 + anticholinergic synergy.",
    "tags": [],
    "id": "Q084"
  },
  {
    "type": "WR",
    "category": "IV Fluids & Blood",
    "question": "Document an IV fluid plan for hemorrhagic shock (prehospital).",
    "rubric": "Permissive hypotension SBP 90\u2013100, 3:1 crystalloid rule, monitor overload, consider rapid transport.",
    "sample_answer": "State NS or RL considerations.",
    "tags": [],
    "id": "Q085"
  },
  {
    "type": "SA",
    "category": "Intro/Legislation",
    "question": "List the Seven Rights and the 3 Cs + E.",
    "rubric": "All seven plus color/clarity/concentration/expiry.",
    "sample_answer": "Ensure wording is correct.",
    "tags": [],
    "id": "Q086"
  },
  {
    "type": "SA",
    "category": "PharmKinetics/Dynamics",
    "question": "Work the half\u2011life example: 1 mg; t\u00bd=3 min; how much remains at 9 min? Show steps.",
    "rubric": "0.5 mg at 3; 0.25 at 6; 0.125 mg at 9.",
    "sample_answer": "Show arithmetic.",
    "tags": [],
    "id": "Q087"
  },
  {
    "type": "SA",
    "category": "Cardiology Meds",
    "question": "Give two ASA contraindications and one caution.",
    "rubric": "Active GI bleed, allergy; caution with anticoagulants.",
    "sample_answer": "Link to Reye's in children.",
    "tags": [],
    "id": "Q088"
  }
]